Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARHGAP18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PAX8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAS2L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIN2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OPRM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLEC4F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEMA7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1orf53 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABLIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHROOM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MFAP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSK3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARMC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PPP2R2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SRSF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC141 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPGRIP1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLF15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HRH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on